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Abstract.  Proteoglycans are expressed in various tis- 
sues on cell surfaces and in the extracellular matrix 
and display substantial heterogeneity of both protein 
and carbohydrate constituents.  The functions of in- 
dividual proteoglycans of the nervous system are not 
well characterized,  partly because specific reagents 
which would permit their isolation are missing.  We re- 
port here that the monoclonal antibody 473HD, which 
binds to the surface of early differentiation stages of 
murine astrocytes and oligodendrocytes, reacts with 
the chondroitin sulfate/dermatan  sulfate hybrid epitope 
DSD-1 expressed on a central nervous system chon- 
droitin  sulfate proteoglycan designated DSD-1-PG. 
When purified from detergent-free postnatal days 7 to 
14 mouse brain extracts, DSD-1-PG displays an appar- 
ent molecular mass between 800-1,000 kD with a 
prominent core glycoprotein of 350-400 kD. Poly- 
clonal anti-DSD-1-PG antibodies and monoclonal anti- 
body 473HD react with the same molecular species as 
shown by immunocytochemistry and sequential immu- 
noprecipitation performed on postnatal mouse cerebel- 
lar cultures,  suggesting that the DSD-1 epitope is re- 
stricted to one proteoglycan.  DSD-1-PG promotes 
neurite outgrowth of embryonic day 14 mesencephalic 
and embryonic day 18 hippocampal neurons from rat, 
a process which can be blocked by monoclonal anti- 
body 473HD and by enzymatic removal of the DSD- 
1-epitope. These results show that the hybrid glycos- 
aminoglycan structure DSD-1 supports the morpholog- 
ical differentiation of central  nervous system neurons. 
T 
hE formation  of specific intercellular  connections  be- 
tween defined  neuronal  assemblies is a crucial step 
during the development of the central  nervous system 
(CNS) 1.  Current  concepts  suggest  that  advancing  growth 
cones are at least partially guided by selective  interactions 
with their local environment  (Bixby and Harris, 1991). Sev- 
eral adhesion molecules have been identified  which play a 
role  in  this  context,  for  example  members  of  the  Ig- 
superfamily  which  support neurite  fasciculation  and  pro- 
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mote advancement  of growth cones along  axonal pathways 
(Jessell,  1988; Hortsch and Goodman, 1991; Rathjen,  1991; 
Schachner,  1991; Walsh and Doherty,  1991), or cadherins 
which regulate neuronal process extension on astrocyte and 
muscle cell surfaces (Bixby et al.,  1987; Tomaselli et al., 
1988; Takeichi,  1991). These latter processes also involve 
integrins,  a family of extracellular  matrix (ECM) receptors, 
implying that the ECM contributes to growth cone guidance. 
Consistent  with this assumption  several ECM glycoproteins 
such as laminin,  thrombospondin, vitronectin,  and tenascin 
have been shown to promote neurite outgrowth from a vari- 
ety of peripheral nervous system (PNS) and CNS neurons 
(Sanes,  1989; Hortsch and Goodman,  1991; Reichardt  and 
Tomaselli,  1991; Hynes and Lander,  1992). In addition pro- 
teoglycans  (PGs) of the ECM which consist of a glycopro- 
tein core with covalently  linked  glycosaminoglycan  (GAG) 
chains (Hassel et al., 1986; Ruoslahti,  1988), may also play 
a role in neuronal fiber formation.  For example, heparan sul- 
fate proteoglycans  (HSPGs) support neurite growth, in sev- 
eral cases as components of laminin-containing  glycoprotein 
complexes  (lander  et  al.,  1985a,b;  Chiu  et  al.,  1986; 
Hantaz-Ambroise  et al.,  1987; Matthiessen et al.,  1989). 
Tissue  fractionation  studies  performed  with  rat  brain 
revealed  that most HSPGs are tightly  associated with cell 
membranes,  whereas  chondroitin  sulfate  proteoglycans 
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the CNS, are recovered in detergent-free salt extracts (Kiang 
et al.,  1981; Klinger et al.,  1985;  Margolis and Margolis, 
1989; Herndon and Lander, 1990). Not very much is known 
about the contribution of CSPGs to neurite growth or to the 
development of neural tissues. A major CSPG of rat brain 
has been characterized in more detail and found to be ex- 
pressed  first by Bergmann glia and subsequently also by 
granule cells in the developing rat cerebellum (Aquino et al., 
1984a,b).  Recent observations show that chondroitin sul- 
fate/keratan  sulfate proteoglycans  (CS/KSPGs)  are  tran- 
siendy expressed in discrete areas, for example in the roof 
plate of the developing spinal cord or alongside forming pe- 
ripheral axonal pathways, where they may act as barriers to 
axon advance (Snow  et al.,  1990a,b;  Cole and McCabe, 
1991; Oaldey and Tosney, 1991; Brittis et al., 1992), CSPGs 
are upregulated in CNS lesions and it has been proposed that 
their inhibitory properties might contribute to impairment of 
axonal regeneration in astrocytic scar areas (McKeon et al., 
1991; Bovolenta et al.,  1993;  Pindzola et al.,  1993).  The 
structural characteristics of these PGs, however,  have only 
partially been elucidated. It is known that soluble CSPG 
preparations from postnatal rat brain contain at least eight 
core glycoproteins, which are differentially  expressed during 
rat CNS development (Herndon and Lander, 1990). Accord- 
ing to peptide mapping studies, some of these represent dis- 
tinct molecular species (Oohira et al.,  1988).  Interestingly, 
several  of the core glycoproteins carry the L2/HNK-1 epi- 
tope, a carbohydrate structure also expressed by neural rec- 
ognition molecules (Kruse et al.,  1984,  1985; Chou et al., 
1986; Gowda et al., 1989; Rauch et al., 1991). These reports 
indicate a substantial heterogeneity of CSPGs in the CNS. 
The  detailed  structural  and  functional analysis of the 
growing number of brain CSPGs has hitherto been ham- 
pered by the lack of tools which would permit their charac- 
terization  (Margolis  and  Margolis,  1989;  Rauch  et  al., 
1991). Several mAbs have been described that react specifi- 
cally with individual PGs, such as 1D1, 3H1, and 3F8. These 
mAbs have been used to purify distinct PGs from neural 
tissues and one of these has been characterized with re- 
combinant techniques and named neurocan (formerly 1D1; 
Rauch et al., 1991, 1992). The cellular sources of these PGs 
have, however, not yet been worked out in detail. In this re- 
gard, more is known about CAT 301 and 6B4 which identify 
neuronal CSPGs (Hockfield and McKay, 1983; Maeda et al., 
1992) and NG2 which recognizes a glial CSPG of neural tis- 
sues (Stallcup and Beasley,  1987; Zaremba et al.,  1989). 
Neuronal expression of CAT 301 early during spinal cord de- 
velopment depends on the activation of the NMDA receptor, 
suggesting a  role of PGs in neuronal plasticity (Kalb and 
Hockfield, 1990).  In support of a physiological role of PGs 
in  the  developing  nervous  system,  it  has  recently  been 
reported that a CSPG isolated from rat optic tectum supports 
survival of retinal neurons (Schulz et al.,  1990).  Further- 
more, the astroglial CSPG astrochondrin, which has origi- 
nally been defined by the mAb L5 directed to an N-linked 
carbohydrate component, is involved in cerebellar granule 
cell migration and mediates extension of astrocyte processes 
on collagen and laminin, but not on fibronectin substrates 
(Streit  et  al.,  1990, 1993).  Finally, it has  recently been 
reported that the CSPGs neurocan and 3F8 of rat neural 
tissues  inhibit  homophilic  interactions  of  Ng-CAM  and 
N-CAM and the binding of neurons to these cell adhesion 
molecules  (Grumet  et  al.,  1993).  In  the  light  of these 
findings, we have studied in more detail DSD-I-PG recog- 
nized by mAb 473HD on the surface of immature CNS glia 
(formerly mAb 473)  (Faissner,  A.  1988. Soc.  Neurosci. 
Abstr.  14:920).  We show here that DSD-I-PG purified from 
postnatal mouse brain promotes neurite outgrowth by em- 
bryonic day 14 (E14) mesencephalic and El8 hippocampal 
neurons through the dermatan sulfate (DS)-containing hy- 
brid epitope DSD-1 (for dermatan sulfate dependen0. Part 
of this work has been presented in abstract form (Falssner, 
A. 1988. Soc. Neurosci.  Abstr.  14:920 and Faissner, A., A. 
Lochter, A. Streit, A. Clement, C. Mandl, and M. Schach- 
net.  1993. Soc. Neurosci.  Abstr.  19:435). 
Materials and Methods 
Animals 
For the preparations of single cells from embryonic or postnatal brains, 
CDI rats or NMRI mice were used.  The day a vaginal plug was found was 
designated embryonic day 0 (E0). Female LouXSD rats and New Zealand 
rabbits were used for immunization. All animals were kept at the local fa- 
cility (Versuchstieranlage  des Zentralbereichs Theoretikum, Heidelberg, 
Germany). 
ECM Molecules 
Human  serum  fibronectin was  purchased  from  Boehringer Mannheim 
GmbH (Mannheim, Germany) or purified according to standard protocols 
(Ruoslahti et al., 1982) from outdated human plasma provided by the local 
blood and serum bank. Laminin isolated  from Engeibreth-Holm-Swarm 
mouse sarcoma cells was a kind gift of Dr. K. Kfihn (Max-Planck-Institute 
for Biochemistry,  Munich, Germany) or acquired from GIBCO BRL (Eg- 
genstein,  Germany). Tenascin was  purified as  described (Falssner and 
Kruse, 1990). Chondroitin sulfates A (CS A), B (CS B, dermatan sulfate), 
and C (CS C), keratan sulfate (KS), heparan sulfate (HS), heparin and dex- 
tran sulfate were purchased from Sigma Chemical Co. (Deisenhofen,  Ger- 
many) or ICN Biomedicals  GmbH (Mockenheim,  Germany). 
Enzymes 
Chondroitinase ACI from Flavobacterium  heparinum was reconstituted in 
20 mM Tris-HC1,  100/tg/ml BSA, 10 ~tg/ml ovomucoid, pH 7.4, and diges- 
tions were carded out in 50 mM Tris-HCl, 50 mum Na-acetate,  100/~g/ml 
BSA, and 10 ~tg/ml ovomucoid,  pH 7.4.  Chondroitinase ACII from Ar- 
throbacter aurescens was taken up in 20 mM Na-acetate,  100 ~tg/ml BSA, 
10/~g/ml ovomucoid,  pH 6.0, and digestions  were performed in 100 mM 
Na:acetute,  100 /~g/ml BSA,  and  10/~g/mi ovomucoid,  pH 6.0. Chow 
droitinase B  (dermatanase) from Flavobacterium  heparinum was  recon- 
stituted in 50 mM Tris-HCl, 500/~g/ml BSA, pH 8.0, and digestions  were 
performed in the same buffer. Chondroitinase ABC from Proteus vulgeris 
was dissolved in 20 mM Tris-HC1,  100/~g/ml BSA, and 10 ttg/ml ovomu- 
cold, pH 8.0, and digestion  was carried out in 50 mM Tris-HC1,  50 mM 
Na-acetate,  100 ~g/ml BSA,  10/tg/ml ovomucoid,  and 1 mM PMSF, pH 
8.0. Keratanase from Pseudomonas species was reconstituted in digestion 
buffer consisting of 100 mM Tris-HC1,  100 raM Na-acetute,  1 mM EDTA, 
100 ~g/ml BSA, pH 8.0, with the protease inhibitors 1 mM PMSF,  100 mM 
e-aminocaproic  acid, 5 mM benzamidine-HCl, 0.1 mM pepstatin. Hepari- 
nase from Flavobacterium heparinum and heparitinase were taken up in 50 
mM Tris-HCl, 50 mM Na-acetate, 5 mM CaC12, 100 p.g/ml BSA, pH 7.4, 
supplied with the additives 1 mM PMSF, 0.1 mM pepstatin, 1.0 mM leupep- 
tin. The same buffer was used for digestion experiments.  Enzymes were ac- 
quired from Sigma Chem. Co.  or ICN Biomedicals  GmhH and aliquots 
stored at -70°C. 
Analytical Procedures 
Protein concentrations were measured according to Lowry (Lowry et al., 
1951) and Bradford (1976), with the Bio Rad protein assay 0Bio Rad Labora- 
tories, Munich, Germany) or with the Micro BCA reagent (Pierce Chem. 
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colorimetric assay (Blumenkrantz and Asboe-Hansen, 1973). Chondroitin- 
suifate  A, C,  or heperin were used as standard reference  with identical 
results. 
SDS-PAGE and Western Blots 
SDS-PAGE was performed on 4-10% gradient slab gels (Laemmli, 1970). 
The gels were stained with reducing silver ions (Merril et al.,  1982) or 
Coomassie Blue (Serva, Heidelberg, Germany) according to standard pro- 
tocols. Western blots were carried out as described and developed  with 
Peroxidase-derivatized  secondary  antibodies  or  125I-labeled Protein  A 
(Faissner et al.,  1985,  1988).  In  some cases polyvinylidene difluoride 
(PVDF) membranes (Immobilon; Millipore Corp.,  Bedford, MA) were 
used instead of nitrocellulose and prepared according to the manufacturers 
instructions. Molecular mass standards were myosin, 205 kD; #-galactosi- 
dase,  116 kD; phospborylase b, 97.4 kD; bovine serum albumin, 66 kD; 
egg white albumin, 45 kD; carbonic anhydrase, 29 kD (kit for molecular 
masses  30-200  kD;  Sigma Chem.  Co.);  a2-macroglobniin,  180  kD; 
/3-galactosidase,  116 kD;  fructose~6-phosphate  kinase,  84 kD;  pyruvate 
kinase,  58  kD;  fumarase,  48.5  kD;  lactic  dehydrogenase,  36.5  kD; 
triosephosphate isomerase, 26.6 kD (prestained kit for molecular masses 
27-180  kD;  Sigma Chem. Co.) or 14C-methylated proteins myosin,  205 
kD; phospborylase b, 97.4 kD; BSA, 69 kD; ovalburnin, 46 kD; carbonic 
anhydrase, 30 kD; lysozyme,  14.3 kD (Amersham Buchler GmbH & Co. 
KG, Braunschweig,  Germany; molecular mass markers for electrophoresis, 
10050 t~Ci/mg protein). 
mAbs 
mAb CS-56 reactive with chondroitin sulfates A and C (Avnur and Geiger, 
1984) was purchased from Sigma Chem. Co., a mAb specific for KS was 
obtained from ICN Biomedicals GmbH and a mAb to GFAP was acquired 
from Boehringer Mannbeim. mAbs O1 and 04 to oligodendrocyte  surface 
antigens, to the L2/HNK-1 epitope (clones 334, 336) and to the eeU adhe- 
sion molecule L1 (clone 324) have been described (Sommer and Sehachner, 
1981; Krnse et al.,  1984;  Rathjen and Schachner, 1984).  Rat IgM mAb 
clone HI which was used as control in immunoprecipitation experiments 
stains the surface of GFAP-positive astrocytes in culture.  For production of 
monoclonal antibodies female LouXSD  rats  were immunized intraperi- 
toneally and subcutaneously with 50/~g "rest-L2" glycoprotein  fraction 
from adult mouse brains (Kruse et al.,  1985) emulsified  in complete and 
two times at two-week intervals with the same amount of immunogen dis- 
solved in incomplete Freund's adjuvant. One week later 50/~g of the antigen 
in PBS, pH 7.4, was injected into the tail vein and fusions were carried out 
4  d  thereafter using the mouse myeloma line X-Ag8-653  as described 
(Lngenaur et al.,  1980; Faissner and Kruse,  1990).  Supernatants reactive 
with the antigen were detected with an enzyme-linked immunosorbent assay 
(ELISA,  see below)  and  further characterized by  immunocytology on 
mouse postnatal cerebellar cultures.  Antibody subclasses were determined 
as described (Faissner and Kruse,  1990)  and the rat IgM mAb 473HD 
(Faissner,  A.  1988. Soc. Neurosci. Abstr.  14:920) was chosen for further 
study.  For large scale production of antibody the hybridoma clone was 
grown in RPMI containing 1% vol/vol Nutridoma (Boehringer Mannheim) 
and the supernatant concentrated by (NI-h)2SO4 precipitation. SDS-PAGE 
revealed a purity of more than 95 % of the antibody. 
Polyclonal Antibodies 
Folyclonni antibodies to vimentin and glial fibrillary acidic protein (GFAP) 
were purchased from Sigma Chem. Co. and Dako Dingnostika  OmbH 
(Hamburg,  Germany),  respectively,  polyclonal  antibodies  to  N-CAM (Trot- 
ter  ct  al.,  1989)  were  a  kind  gift  of  Dr.  J.  Trotter  (Department  of  Neurobiol- 
ogy, Heidelberg,  Germany), and polyclonal  antibodies  to LI, laminin, 
fibronectin,  and  tenascin  (pTN)  have  been  de,  scribed  elsewhere  (Rathjen  and 
Schachner,  1984;  Falssner  et  al.,  1985;  Pesheva  et  al.,  1989;  Faissner  and 
Kruse, 1990).  For  production  of  polyclonal  antibodies  to  the  DSD-l-proteo- 
glycan  (pDSD-I-PG), 50-100 #g of  uronic  acid  equivalents  of  the  purified 
material  (see  below)  emulsified  in  Freund's  adjuvants  were  injected  into  rab- 
bits  at  multiple  sites  subcutaneously  on  the  back  and  the  animal  was  boosted 
at three-week intervals  with the same amount of antigen  in incomplete 
Freund's  adjuvants.  One  week  after  the  third  boost  a  first  bleed  was  collected 
(KAFI  3  [I]).  Subsequently,  the  rabbit  was  boosted  repeatedly  after  recovery 
phases of  six  weeks and serum was collected  one week after  each boost. 
IgG-fractions were prepured by  affinity  chromatography  on protein 
A-Scpharose  following  standard  protocols  (Falssner  and  Kruse, 1990).  Af- 
ter dialysis against PBS, 0.05% wt/vol NaN3 the IgG fractions were con- 
centrated to 4.0°5.0  mg/ml by pressure dialysis using PM30 membranes 
(Amicon, Wttten, Germany) and stored at -70"C. IgGs from the fourth 
bleed (KAF13[4]) were used throughout for all the experiments detailed in 
this manuscript. Peroxidase-  and alkaline phosphatase-derivatized second- 
ary antibodies to rabbit, mouse and rat Igs were obtained from Promega 
Corp. (Madison, WI), Cappel Labs. (Cochranville, PA), or Dianova (Ham- 
burg, Germany). 
Purification of DSD-1-PG 
For preparation of DSD-1-PG detergent-free extracts (Hoffman and Edel- 
man, 1987; Faissner and Kruse, 1990) of postnatal day 1 (Pl) to P15 mouse 
brains were sequentially  circulated with a flow rate of 20 ml/h at 4"C over 
gelatin Sepharose,  Sepharose 4B coupled with 5 mg/ml rat IgG, or 1 mg/ml 
mAb 473HD (lO-ml bed volume each). Coltmms were washed with 30-bed 
volumes PBS, llYbed volumes PBS containing 0.5 M NaC1 followed by 10- 
bed volumes PBS and finally eluted with 2-bed volumes 0.1 M diethylamine, 
0.1 M NaCI, 1 mM EDTA, and 1 mM EGTA, pH 11.5. The column eluates 
were neutralized by addition of 0.1 n HC1, dialyzed  against PBS, concen- 
trated in Amicon chambers, and stored at -70"C. Protein concentration 
(Micro BCA; Pierce Biochemicals) was about 20 ttg/ml; 3 ml of eluate were 
obtained per preparation. For ion exchange chromatography on MONO Q 
columns (Pharmacia LKB, Preiburg, Germany) 2 ml ofmAb 473HD eluate 
were dialyzed  against 8  M  Urea,  50 mM  Na-acetate,  pH  6.0  (loading 
buffer), concentrated to 0.5 ml in Ceutricon tubes (Amicon), loaded on the 
column, and subjected to a linear salt gradient from 0 to 1.5 M NaC1 in 
loading buffer. 40 1-mi fractions were collected.  Gel filtration was carried 
out on Superose  6 (Pharmacia LKB) with 0.5 ml of mAb 473HD-positive 
material in 4.0 M guanidinium-hydrochloride,  50 raM Na-acetate, pH 6.0, 
and 45 fractions were obtained. Fractions containing mAb 473HD im- 
munoreactivity were identified by ELISA (see below). For preparative pur- 
poses eluates from several preparations were loaded on Q Sepharose  with 
a super-loop device and eluted in two steps of 0.5 and 1.0 M NaCI (Streit 
et al.,  1990).  Immunoreaetive fractions (all at 1.0 M NaC1) were pooled, 
dialyzed  against H20,  lyophilized,  and taken up in PBS. In such prepara- 
tions, concentration of uronic acid and protein were about 40 ~g/rul and 5-7 
/~g/ml (or not measurable), respectively. About 500 ttg uronic acid equiva- 
lents were isolated from 5,000 mouse brains and the resulting material was 
defined as DSD-1-PG. In some cases, supernatants of subeultured human 
embryonic fibroblasts  (Faissner and Kruse,  1990)  instead of postnatal 
mouse brain extracts were used as starting material for purification of DSD- 
1-PG, following the same protocol. 
ELISAs 
Clone supernatants resulting from the fusion experiments were tested by an 
immunospot test on nitrocellulose filters using the immunogen "rest-L2," 50 
t~g/ml, 3 ttl per spot (Hawkes et al.,  1982).  For analysis of DSD-I-PG by 
ELISA with mAb 473HD and other mono- or polyclonal antibodies, 100-td 
aliquots were taken from fractions of ion exchange or size exclusion chro- 
matography columns, cell culture supernatants, tissue extracts or DSD-1- 
PG preparations (the latter at 2 ttg/mi uronic acid equivalents)  and spored 
onto nitrocellulose sheets using the Minifold dot blot device (Sehleicher & 
Schuell,  Dassel, Germany). For investigation of mAb 473HD binding to 
immobilized GAGs, carbohydrates were directly applied to the filter at 1, 
10, or 100 ~g/ml in PBS, with 1-2/~1 per spot. In some eases, GAGs were 
digested  with GAG-lyasos prior to application to nitrocellulose.  Subse- 
quently, the nitrocellulose sheets were washed twice with 50 ~  Tris-HC1, 
150 told NaCI,  pH 7.4 (TBS),  treated with blocking buffer consisting of 
delipidated milk powder, 4 % wt/vol in TBS supplemented with 0.1% wt/vol 
Tween 20, washed once with TBS, 0.5%  wt/vol Tween 20 (TBS-Tween), 
and incubated overnight with mAb 473HD (1-5 #g/ml) in blocking buffer. 
Thereafter, filters were rinsed three times with TBS-Tween,  incubated for 
2 h with pemxidase-derivatized anti-rat Ig in blocking buffer, washed three 
times with TBS-Tween,  and developed  with ABTS or diaminobenzidine 
color substratum. Alternatively, mAb 473HD column eluates or DSD-I-PG 
preparations were adsorbed overnight to polyvinyl-pymlidone (PVP; Fal- 
con Plastics,  Cockeysville,  PA) plates at 0.5 ttg/ml uronic acid equivalents 
in 0.1 M NaHCO3,  pH 8.0, 100 ttl per well.  The wells were blocked for 
at least I h with 0.1 M NaHCO3,  1% wt/vol BSA, pH 8.0, 200 td per well 
and washed twice with 0.1 M NaHCO3,  pH 8.0. Subsequently,  PVP plates 
were incubated with antibodies diluted in PBS, 0.5%  wt/vol BSA,  100 t~l 
per well, for at least two hours or overnight, washed four times with PBS, 
0.05%  wt/vol Tween 20 (PBS-Tween),  incubated for two hours with per- 
oxidase-derivatized  secondary  antibodies  in  PBS,  0.5%  wt/vol  BSA, 
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and Kruse,  1990).  The colored reaction product was quantified  with an 
ELISA reader at 405 nm (Titertek multisean; Flow Labs., Inc.). FOr diges- 
tion of DSD-1-PG  with specific  GAG-lyases before  antibody incubation, 
nitrocellulose  filters, or PVP plates containing the PG were washed twice 
with the corresponding digestion buffer (see Enzymes) after the blocking 
step.  Thereafter,  filters  or  microtiter wells  were  incubated with chon- 
droitinases ACI, ACII, ABC, or keratanase at 10-100 mU/rrd or heparinase 
and heparitinase at 1 U/ml for 3 h at 37°C,  washed twice with adequate 
buffers, and processed for ELISA with mAbs 473HD or 336 (directed  to 
the L2/HNK-l-epitope)  as described above. FOr competition assays, 1 t*g/ml 
of purified mAb 473HD was preincuhated with defined GAGs (50 t~g/ml if 
not indicated otherwise) for 1 h at 37"C and used for ELISA on DSD-I-PG 
in the presence of the competitors. 
Iodination of  DSD4-PG 
For iodination  using the Bolton-Hunter  or the iodogen procedure DSD-1-PG 
(20-30/zg of uronic acid equivalents)  was dialyzed  against 8.0 M  urea, 
0.1 M NaH2POdNa2HPO4,  pH g,1, and concentrated to 300 t~l in Centri- 
con 30 tubes (Amicon). The BoRon-Hunter reagent  was dried under a 
stream of nitrogen, the PG was incubated with the ester for 30 rain at room 
temperature and the reaction was stopped by the addition of 40 #1 1.0 M 
glycine. Unbound radioactivity was removed by filtration  on Sephadex (310 
(coarse)  in 8.0 M Urea, 0,1 M NaC1, 0.1 M NaH2POdNa2HPO4,  pH 7.4 
(Faissner et al.,  1990).  Peak  fractions were  monitored by ,y-counting, 
pooled, and stored at 4°C. Under these conditions, 10-25 ttCi were incor- 
porated into the PG and the specific activity was 5-10/~Ci per #g protein. 
For iodination according to the iodogen procedure (Salacinski et al., 1980, 
the concentrated PG was incubated with 1 mCi Nat2SI and one iodogen 
bead (Pierce Chem.  Co.)  in a  test tube coated with iodogen  (1,3,4,6- 
tetrachloro-3,6,-Dl-phenylglucouril;  Sigma Chem. Co.; 40 ~tg/rnl in methy- 
Iene chloride [dichloromethane,  Sigma Chem. Co.], 0.5 ml per test tube 
dried under an N2 stream) for t5 rain and subsequently treated as de- 
scribed for the Bolton-Hunter procedure.  Incorporation was 25-50 tzCi per 
/xg of protein. For digestion with GAG-lyases, the iodinated PG was precipi- 
tated twice with 70% vol/vol ethanol in water, dried, and incubated with 
chondroitinases  ACI (100 mU), ACII (100 mU), ABC (100 mU), keratanase 
(100 mU), heparinase (1.0 U), or heparitinase (1.013) for 3 h at 37°C in ade- 
quate incubation buffers as detailed in Enzymes, The reaction was inter- 
rupted by addition of twofold concentrated sample buffer for PAGE. The 
digested material was resolved on 4-10% gradient slab gels and the gels 
were processed  for autoradiography as described (Faissner et al.,  1988). 
1Issue Fractionation and Digestion 
To analyze the solubilization properties of DSD-1-PG, P6-P14 mouse brains 
were  homogenized  by  10  strokes  with a  dounce homogenizer at a  1:5 
(wt/vol)  ratio  in  the  following  buffers:  A,  10  mM  Tris-HCl.  4  M 
guanidinium-HC1,  and 5 mM EDTA, pH 7.4; B, 140 raM NaCl, 4 mM KCI. 
15 mM NaHCO3,  10 mM glucose,  0.2 mM NaH2PO4-H20, and 0.2 mM 
KH2PO4, pH 7.4; C,  100 mM diethylamine,  100 mM NaC1, and 2 mM 
EDTA, pH 11.5; D, 100 mM diethylamine,  60 mM N-octylglucopyranosid, 
and 2 mM EDTA, pH 11.5; E, 20 told Tris-HC1,  5 mM EDTA, and 60 
mM N-octyiglucopyranosid,  pH 8; F, 10 mM Tris-HC1,  2 M Urea, 2 mM 
EDTA, and 2 mM EGTA,  pH 8.5; and G, 50 mM Tris-HCi, 50 mM Na- 
acetate,  and 60  mM  N-octylglucopyranosid,  pH  8.  Buffers  A-G were 
replenished with I0 #g/ml uvomucoid,  I mM PMSF,  I/zg/n-d aprotinin, 10 
/,g/ml SBTI, 5/~g/ml leupeptin, (3.1/~g/ml pepstadn, 1/,g/nil antipain, and 
1/~g/ml tx2-macroglobulin.  Homogenates  were stirred at 4"C for 60 rain 
and subsequently cleared by centrifugation at 10,000 g for 10 rain. Superna- 
tants were  carefully  removed and extracts in buffers A-F were dialyzed 
twice against a 100-fold volume of 50 mM Tris-HCl, 50 mM Na-acetate, 
and 1 mM PMSE pH 8, cleared  again at 10,000 g, 4°C, for 10 min, and 
aliquots removed for digestion  with GAG-lyases. To this end, cleared  ex- 
tracts in buffers A-G were replenished with 100/~g/ml BSA (RIA-grade), 
10 t~g/ml uvomucoid,  and 1 mM PMSE pH 8, and incubated with chon- 
droitinase ABC (15 mU per 50 t~l of extract) or without addition of enzyme 
(control) for 2 h at 370C. Digestion was terminated by addition of 4x con- 
centrated SDS-PAGE sample buffer and probes were resolved  on 4-10% 
SDS-PAGE gradient slab gels, subjected to Western blotting and the filters 
finally  developed  with m.Ab 473HD or pDSD-1-PG antibodies and 1251- 
derivatized  secondary reagents (see above).  FOr documentation of DSD-1- 
PG in rat CNS,  El8 hippocampi were obtained by microdissecfion  and 
transferred to ice-cold HBSS, freed from meninges and immediately  frozen 
in an Eppendorf tube placed into liquid nitrogen.  12 pooled hippocampi 
were homogenized in 2 ml of buffer G and resulting tissue extracts (contain- 
ing 200 #g/mi protein according to the Bio Rad protein assay) were subse- 
quently processed for digestion with chondroitinase ABC and Western blot- 
ting essentially as described for postnatal mouse brain extracts (see above), 
In some cases, 50-#l aliquots of  chondroitinase ABC treated and control ex- 
tracts were used for dot blot and subsequent ELISA as detailed earlier (see 
ELISAs). 
Preparation of  CeU Culture Substrates 
For preparation of coated substrates,  multichamber culture slides  (Falcon 
Plastics) were incubated for 1-2 h at 37°C with 1.5 ttg/ml poly-DL-ornithine 
(PORN; Sigma Chem. Co.) in 0.1 M borate buffer, pH 8.2 (Collins, 1978). 
Preliminary control experiments had shown that coating with low concen- 
trations of PORN as compared to uncoated plastic does not notably impair 
embryonic hippocampal neuron differentiation.  The wells  were  washed 
twice with distilled water, air dried, incubated overnight at 37°C with PBS 
or PBS containing 5 #g/ml uronic acid equivalents  of DSD-1-PG (both at 
100 #l/well) sterilized by passage through filters with low protein-binding 
capacity  (Millex  GV4;  Millipere Corp.),  and finally washed  twice with 
PBS. For some experiments DSD-1-PG was heat-treated  by boiling for 10 
min before coating.  When cell culture was carried out in the presence of 
antibodies or for digestion with GAG-lyases,  the culture substrates were 
blocked for 2 h with heat-inactivated  BSA (15 rain at 80°C, 5 mg/mi in PBS) 
after the coating step. Digestion was subsequently  carried out with chon- 
droitinases ACII or ABe with 100 t~l of enzyme per culture well (2 U/ml 
in incubation buffer) for 3 h at 37°C. Thereafter,  culture wells were washed 
with ddH20  before  cell  plating.  The  adsorption  of  DSD-I-PG  to  the 
PORN-conditioned culture substrates after overnight coating, after incuba- 
tion with antibodies or after enzyme treatments, both before cell plating and 
after the 24-h culture period, was monitored by ELISA. To this end, mAbs 
473HD and 336 or pDSD-1-PG were applied in a final volume of 250 t~l 
per microchamber well. In addition, the efficiency of chondroitinase ACII 
and ABe treatment in removing the GAG chains of DSDd-PG was assessed 
with mAb CS-56. Development of the ELISA was performed as described 
above and the soluble color product was measured with an ELISA reader 
after transfer to microtiter plates. 
Cell Culture 
Hippoeampal  cell cultures were established from embryonic day 18 (Elg)- 
El9 rat brains (Banker  and Cowan, 1977) with some modifications (Lochter 
et al.,  1991). Hippocampi were obtained by microdisseetion, placed in 
HBSS,  freed from meninges,  and incubated in HBSS containing 0.25% 
wt/vol trypsin (GIBCO BRL) for 10 rain at 37°C.  After three washes in 
HBSS,  hippocampi were dissociated  by trituration in HBSS containing 1 
mM Mg2SO4 and 0,025%  wt/vol DNase I (Boehringer Mannheim) using 
fire-polished Pasteur pipettes. The resulting cell suspension was centrifuged 
at 80 g for 10 rain at room temperature and the pellet resuspended in chemi- 
cally defined medium (but without putrescine) (Rousselet et al., 1988) con- 
sisting of DME with Ham's FI2 solution (DME/F12 1:1; GIBCO BRL), 2.4 
mg/ml NaHCO3, 33 mM wglucose, 2 mM L-glutamine, 25 ttg/ml insulin, 
100/~g/ml  transferrin, 2  ×  10  -s M progesterone,  3  x  10  -s M selenium, 
0.1% (wt/vol)  ovalbumin,  5 mM Helms, 5 IU/ml penicillin, and 5 ttg/ml 
streptomycin.  Monolayer cultures from single cell suspensions from mesen- 
cephalon were prepared from E14-E15 rats and plated in defined medium 
(Chamak and Prochiantz, 1989). 90% of the mesencephalic and 98 % oftbe 
hippocampal cells were viable as judged by trypan blue exclusion.  All cells 
were plated at a density of 10,000 cells/cm  2 in 250 td medium per well and 
maintained in this medium for 24 h. The plating efficiency of hippocampai 
neurons 1.5 and 24 h after plating was ,~,70% on all substrates.  Viability 
of cells as determined by trypan blue exclusion after 24 h of culture was 
60% on PORN and 80% on PORN with substratum-bound DSD-1-PG. Cul- 
tures of both hippocampal and mesencephalic cells were estimated to be 
98% pure neurons by morphological (Banker and Cowan,  1977, for hip- 
pocampal cultures) or immunological (for mesencephalic cultures, Chamak 
and Prochiantz, 1989) criteria. To test the influence of mAbs on the effect 
of  substratum-bound  DSD-I-PG,  mAb  473HD  was  dialyzed  against 
DME/F12 and sterilized  by filtration (Millex GV4; Millipore Corp.). The 
wells were incubated for 2 h at 37°C with 20 tzg/ml ofmAb 473HD in PBS 
and washed twice with PBS prior to cell plating.  An equal concentration 
of antibodies was added to the culture medium 1 h thereafter.  The mAb 
473HD did not affect the survival  rate of hippocampal neurons.  Primary 
mouse cerebellar and El4 mouse or subcultured  human embryonic fibro- 
blast cultures  were  established as  described  and cultivated  on  pely-l- 
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Schachner, 1981; Kruse et al.,  1985;  Faissner and Kruse, 1990). 
Histochemical and Immunocytological Staining of 
Cultured Cells 
For histocbemical staining, cultures were fixed in PBS containing 2.5% 
(vol/vol) glutaraldehyde for 1 h at room temperature. After two washes with 
PBS, cells were stained for 15 rain with 0.5 % (wt/vol) toluidine blue (Sigma 
Chem. Co.) in 2.5%  (wt/vol) Na2CO3,  washed twice with distilled water 
and air dried. For immunochemical staining with peroxidase-derivatized 
secondary antibodies, cultures were fixed with 4% (wt/vol) paraformalde- 
hyde in PBS for 15 rain at room temperature, washed twice with PBS, and 
blocked for 10 rain with 10% (vol/vol) horse serum in PBS. Cultures were 
then incubated for 30  min at 37"C  with polyclonal N-CAM antibodies 
(1:200)  in PBS containing 10%  (vol/vol) horse serum, washed twice with 
PBS, and incubated for 30 rain at 37"C with peroxidase-coupled secondary 
antibodies to rabbit IgG (1:1,000) in PBS containing 10%  (vol/vol) horse 
serum. Subsequently, the cells were washed twice with PBS, incubated with 
0.5 mg/ml diaminobenzidine, 0.015%  (vol/vol) H202 in 10 mM Tris-HCl, 
pH 7.4,  at room temperature, washed twice with distilled water, and air 
dried. For double immunofluorescence labeling, cultures were fixed with 
4 % (wt/vol) paraformaldehyde and subsequently stained with n'tAb 473HD 
or mAb 324 (anti-Ll) followed by anti-rat-FITC, and counterstained with 
polyclonal antibodies to LI, DSD-1-PG,  virnentin, or GFAP which were 
visualized with anti-rabbit-Texas Red, according to published protocols 
(Schnitzer and Schachner, 1981). Cells were permeabflized with ethanol (10 
min at 4"C) prior to application of antibodies directed against the cytoskele- 
ton. When mAbs O1 or 04 were compared with mAb 473HD in double 
immunofluorescenee-stalning experiments,  subclass  specific anti-mouse 
IgM and anti-rat IgM secondary antibodies dedvatized with FITC or Texas 
red were used. These were diluted in the presence of serum from the species 
corresponding to the n'tAb of the counter-stain in order to minimize cross- 
reactions. Thus, anti-mouse IgM-Texas red diluted in the presence of 10% 
(vol/vol) rat serum did not recognize mAb 473HD on cell surfaces express- 
ing the DSD-1 epitope. In some cases, fixation was performed after applica- 
tion of the first or the second antibody or at the end of the staining proce- 
dure. Coverslips were embedded with Moviol 4-88 (Hoechst, Frankfurt, 
Germany) dissolved in PBS, and replenished with the protectant Citifluor 
(Anaersham Buchler). Cultures were viewed with a Zeiss epifluorescence 
microscope  (Axiophot)  and  photographed  with  an  integrated  camera 
system. 
Morphometry and Statistical Analysis 
For quantitative morphometry only singly growing cells were measured and 
only neurites exceeding one cell diameter in length were taken into account. 
Neurite outgrowth was determined as the fraction of process-bearing cells 
from at least 100 neurons per well chosen at random and given in percent. 
Neurons extending processes were further analyzed by evaluating the total 
length of neurites per cell using an Al Tectron image analysis system (VIDS 
HI software). Samples of 50 randomly selected neurons were investigated 
per well. Since the single values obtained were not normally distributed, 
neurite lengths of individual  neurons grown under different conditions 
within an experiment were compared with the Mann-Whitney U-Test, a non- 
parametric statistical procedure. For comparison between independent ex- 
periments, total neurite lengths of 50 neurons for defined experimental con- 
ditions  were  summed and  the  resulting sums  were  evaluated  with the 
Mann-Whitney U-Test. All statistical tests were taken from the textbook by 
Clanss and Ebner (1977).  Graphical representations of results were per- 
formed using  Statview II  TM  (Abacus Concepts Inc.,  Berkeley,  CA), 
Cricket Graph TM  (Cricket Software,  Malvern,  PA),  and Canvas  TM 
(Deneba Software Inc., Miami, FL) at the Zentrum fOr Molekulare Biologic 
Heidelberg, University of Heidelberg. 
Biosynthetic Labeling of  Cell Cultures 
and Immunoprecipitation 
For biosynthetic labeling of sulfate groups, postnatal cerebellar cultures 
were incubated overnight with 50 ;tCi/ml 35SO4 in low sulfate basal me- 
dium Eagle, 10% (vol/vol) horse serum. Thereafter, cultures were washed 
twice with CMF-HBSS and then detergent solubilized in  1 ml ice-cold 
solubilizatiun buffer (0.15 M NaCi, 20 mM Tris-HC1, 1 mM EDTA, 1 mM 
EGTA,  10 mM methionine, 0.5% NP-40, and 0.05%  NAN3, pH Z4) con- 
taining aprotinin, soybean trypsin inhibitor, turkey eggwhite trypsin inhibi- 
tor (all at 10 #g/ml), PMSF, and iodoacetamide (both at 5 raM), and pepsta- 
tin (at 2 uM). After 10 rain on ice, cells were gently scraped off the Petri 
dish, transferred  to test tubes, and kept on ice for another 30 rain. Detergent 
lysates were clea_r~ by centrifugation at 800 g for 10 rain and at 100,000  g 
for 1 h at 4"C and then either stored at -70°C or immediately used for im- 
munoprecipitation. After the end of the labeling period culture superna- 
tants were processed separately, e.g., treated with protease inhibitors and 
centrifuged as described above. Immunopreeipitation was carried out as de- 
scribed (Faissner et al.,  1985).  In brief, 1-ml aiiquots of biosynthetically 
labeled  detergent-solubilized cell extracts  or  culture  supernatants  were 
mixed with 200/~g pDSD-1-PG antibodies, 20 ~g mAb 473HD, or 20 ttg 
mAb clone H1 (negative control) and incubated for at least 1 h on a shaker. 
This and all subsequent steps were carried out at 4"C. The aliquots were 
then incubated for another hour with 120 ~1 of preswollen Sepharose-pro- 
tein A conjugate (Sigma Chem. Co.) in ease of  polyclonal rabbit antibodies. 
For precipitation of mAb 473HD,  monoclonal anti-rat-kappa-light-chain 
antibody coupled to cyanogen bromide activated Sepharose 4B at 3.0 mg per 
1.(3 ml of swollen gel was used (MARK-l) (B~in,  1982),  and 100 t~l of 
MARK-I-Sepharose prepared as 10% vol/vol suspension in solubilizatiun 
buffer were added to a single aliquot. Sepharose beads were washed several 
times and finally resuspended in 65 t~l SDS-sarnple buffer, boiled for 4 min 
at 100*C and centrifuged (8,000 g, 1 rain). The superuatants were counted 
in a B-scintillation counter and in some cases supernatants of precipitates 
collected in parallel experiments were run on 4-10% gradient SDS-POly- 
acrylamide slab gels. For sequential immunopreeipitation, this procedure 
was repeated several times with the same aliquot (Falssner et al.,  1988). 
After eight-cycles of precipitation with pDSD-1 antibodies aliquots were 
cleared with Sepharose-protein A conjugate in order to remove residual 
polyclonal antibodies and finally subjected to one cycle of  precipitatiun with 
mAb 473HD. In the reverse experiment, mAb 473HD was used for eight 
cycles of immunoprecipitation and ensuing clearance was carried out with 
MARK-1-Sepharose  prior to the final precipitation with pDSD-I-PG. Both 
sequences of immunoprecipitation were performed in parallel, starting with 
split aliquots from the same labeled culture. For fiuorography, gels were 
fixed in 10% acetate, 30% methanol in water and subsequently treated with 
"Amplify" as  described by  the  producer  (Amersham Buchler).  Kodak 
XAR-5 films were exposed at -70"C and developed according to the sup- 
pliers instructions. For determination of incorporated activity, two 50-~1 
aliquots from both detergent extracts or culture supernatants were incubated 
with acetone (80% vol/vol, -20°C overnight) or TCA (20% wt/vol, 60 rain 
on ice). Precipitates were collected  by centrifugation at 12,000 g for 15 min, 
washed once with ethanol/diethyl ether (1:1 vol/vol) and finally recovered 
at 12,000 g for 10 min. The resulting pellets were dried, dissolved in heated 
SDS-PAGE sample buffer, boiled for 5  min, and finally quantified in a 
B-scintillation counter. 
Results 
mAb 473HD Identifies DSD-1-PG in the Mouse CNS 
The rat IgM mAb 473HD reactive with the molecule desig- 
nated DSD-I-PG was obtained by generating mAbs against 
glycoproteins carrying the L2/HNK-l-epitope, a  carbohy- 
drate strt!cture common to  several recognition molecules 
and PGs of the rodent central nervous system, mAb 473HD 
immunoprecipitates chondroitinase ABC-sensitive compo- 
nent(s) from 35SO4-1abeled G26/20 glioma cell culture su- 
pernatants which migrate as a polydisperse smear at 1,000 
kD, suggesting that DSD-1-PG  is soluble in the absence of 
detergents (Faissner, A. 1988. Soc. Neurosci. Abstr. 14:920). 
For biochemical characterization, the molecule was there- 
fore enriched from detergent-free, physiological saline ex- 
tracts of early postnatal day 8 (P8) to P15 mouse brains by 
immunoattinity chromatography on a mAb 473HD colunm. 
The resulting column eluates were further purified by ion ex- 
change chromatography where DSD-1-PG  eluted at 1.0 M 
NaC1 (Fig. 1 A). In gel filtration experiments, DSD-1-PG ob- 
tained by this two-step procedure migrated as peak between 
800 and 1,000 kD in the presence of  4.0 M guanidinium-HCl 
(dissociative conditions) (Fig. 1 B). Analogous results were 
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Figure L Analysis of  DSD-1-PG by fast performance liquid chroma- 
tography.  DSD-1-PG-containing  glycoprotein  fractions  were en- 
riched  by  immunoaffinity  chromatography  on  a  mAb  473HD 
column,  as described  in Materials and Methods.  Column eluates 
were further processed by ion exchange chromatography  (A) and 
subsequent size exclusion chromatography  (B). (A) mAb 473HD 
immunoreactive fractions (OD405, black triangles) eluted at 1.0 M 
NaCI (linear slope) from MONO Q Sepharose, in contrast to the 
majority  of proteins  (OD280, open  circles).  (B) Immunoreactive 
material obtained in A was recovered as one peak between 800 and 
1,000 kD in 4.0 M guanidinium-HC1 on Superose 6. Arrows indi- 
cate Vo and Vt. 
obtained when the sequence of chromatography steps was 
reversed  (not  shown).  Our  purification  protocol  yielded 
,,0200  ng uronic acid equivalents of DSD-1-PG per 1 gram 
brain tissue (wet weight). Because of this low yield, purified 
DSD-1-PG had to be radioactively labeled with t25I for visu- 
alization  and  enzymatic  digestion  studies.  The  radioiodi- 
nated molecule appeared as a broad smear commencing at 
1,000 kD by SDS-PAGE and was sensitive to chondroitinase 
ACII  and  ABC,  but  not  to  other  GAG-lyases  (Fig.  2). 
Removal of GAGs both by chondroitinase  ACII and ABC 
resulted  in  a  prominent  component  of  molecular  mass 
350-400 kD and, in a minority of cases (not shown), in faint, 
diffuse bands in the range of 240 and 180 kD with less than 
10 % of the total radioactivity. These might represent degra- 
dation products of the large component or additional species 
reactive with mAb 473HD which are expressed at lower lev- 
els or not recovered in substantial amounts by the isolation 
procedure.  Thus,  variations in the migration properties of 
DSD-1-PG which were also observed within the same batch 
may  reflect  the  technical  difficulties  to  resolve  highly 
Figure 2.  Analysis of DSD-I- 
PG  by  digestion  with  gly- 
cosaminoglycan  lyases.  125I- 
labeled  DSD-I-PG  (10  s cpm 
per  lane)  was  precipitated 
with  ethanol  and  incubated 
with  chondroitinase  reaction 
buffer  devoid  of enzyme or 
digested  with  chondroitina.~e 
ACII,  cbondroidnase  ABC, 
heparina~,  beparitinase,  or 
keratanase as indicated in the 
figure,  boiled  in  sample 
buffer, and resolved by SDS- 
PAGE on 4-10% gradient slab 
gels.  An  autoradiography  of 
the gel  is  shown.  Molecular 
mass marimrs indicated at the 
left margin were laminin A chain (400 kD), fibronectin (220 kD), 
laminin B chain (200 kD), c~2-macroglobulin  080 kD), and B-gala.c- 
tosidase  (116 kD). 
charged polydisperse molecules by SDS-PAGE. In contrast 
to chondroitinase ABC, heparinase,  heparitinase,  and ker- 
atanase did not significantly affect the migration behavior of 
DSD-1-PG by SDS-PAGE, consistent with the notion that it 
constitutes a CSPG and did not react with an mAb to keratan 
sulfate (KS) in ELISAs (Fig. 2, and not shown).  The yield 
of DSD-1-PG from postnatal mouse brain comprised 200 ng 
uronic acid equivalents and 20-40 ng of protein per g  wet 
weight. Soluble P0 rat brain extract encompass at least nine 
distinct PGs with an overall concentration of 15 #g protein 
per g  of tissue (wet weight)  (Herndon and Lander,  1990) 
which corresponds to an average content of 170 ng PG pro- 
tein. From this point of view, and considering its restricted 
distribution,  the  estimated concentration  of DSD-1-PG in 
postnatal mouse brain is not surprisingly low. 
DSD-1-PG 
' •  DSD-1 -PG +  Ch-ase ABC 
~  ~  8  8 
Dilution  of  pDSD-1-PG 
Figure  3.  Specificity  of polyclonal  anti-DSD-I-PG antibodies. 
Laminin (LN, open triangles) and tenascin (TN, fiUed circles, both 
at 1.0 #g/ml)  and DSD-I-PG (0.5/~g/ml  uronic acid equivalents) 
were coated to wells of a PVP plate. The PG was not further treated 
(open  squares)  or  digested  with  chondroitinase  ABe  (filled 
squares) after adsorption to the substrate.  The ELISA was devel- 
OlXXt with a dilution row of pDSD-1-PG and a soluble color sub- 
strate  (ABTS, OD at 405  rim).  Note that the  antibodies  do not 
cross-react  with laminin or tenascin  and show higher  affinity to 
DSD-I-PG after removal of the GAG complement. Starting concen- 
tration  (1:250) corresponded  to 20 #g/rnl of IgG. 
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postnatal day 8-15 mouse brains (prepared in 50 mM Tris-HC1, 50 
mM Na-acetate, 60 mM N-octylglucopyranoside, pH 8, including 
protease inhibitors) were incubated with chondroitinase ABC or 
without addition of enzyme (control) as indicated in the figure. 
Samples were resolved by SDS-PAGE  in 4-10% gradient slab gels, 
transferred by Western blotting and filters were developed with 
mAb 473HD,  pTN, and pDSD-1-PG antibodies and  z25I-defiva- 
tized secondary reagents. Note that the DSD-I epitope is present 
on polydisperse material migrating from 600-1000 kD and is re- 
moved by enzyme treatment. Digestion of GAGs yields one core 
glycoprotein of 350-400 kD. Tenascin is not affected by enzyme 
treatment, as expected. An autoradiograph is shown, exposures had 
to be prolonged for visualization of the pDSD-1-PG signal on the 
undigested extracts, presumably because of reduced affinity for the 
intact PI3 0ast lane on the fight).  Under these conditions,  faint 
bands at 230 and 110 kD emerge which are negligible in compari- 
son to the intensity of the signal obtained on the chondroitinase 
ABC treated material.  Molecular mass markers indicated at the 
right margin were laminin A chain (400 kD), fibronectin (220 kD), 
laminin  B  chain  (200  kD),  cx2-macroglobulin (180 kD),  and 
/~-galactosidase (116 kD). 
To establish that DSD-1-PG represents a  defined entity, 
pDSD-1-PG against the purified molecule were raised in rab- 
bits.  Expectedly,  the  polyclonal  antibodies  reacted  with 
DSD-1-PG adsorbed to PVP plates but did not recognize the 
ECM  glycoproteins  tenascin,  laminin,  or  fibronectin  in 
ELISA (Fig.  3 and not shown).  The polyclonal antibodies 
showed a  higher affinity towards the core glycoprotein of 
DSD-1-PG than for the intact molecule, as evidenced by in- 
creased  reactivity  after  treatment  of the  PG  with  chon- 
droitinase ABC (Fig. 3). Enzyme treatment and the release 
of the GAG-chains did not detach the core protein from the 
PVP wells (Fig. 3). The specificity of  the polyclonal antibod- 
ies  to  DSD-1-PG  was  confirmed in  Western blot experi- 
ments. Extracts from P8 to P15 mouse brains were digested 
with chondroitinase ABC prior to SDS-PAGE.  The poly- 
clonal antibodies reacted with a polydisperse smear begin- 
ning in the range of 1,000 kD apparent molecular mass in 
untreated samples and visualized a major band of 350--400 
kD in CNS homogenates digested with chondroitinase ABC, 
in accordance with the characteristics of purified DSD-1-PG 
(Figs. 2 and 4). To exclude that further components reactive 
with  the polyclonal antibodies are expressed in  compart- 
ments of the CNS not accessible to physiological saline ex- 
traction,  P6-P14  mouse  brains  were  homogenized under 
various conditions including urea-, guanidinium hydrochlo- 
ride-,  or  detergent-containing buffers  and  high  pH.  The 
homogenates were subsequently processed for chondroitin- 
ase digestion and SDS-PAGE and analyzed by Western blot- 
ting, with essentially the same results as described above (Ta- 
ble I).  It has to be kept in mind,  however, that additional 
DSDq-PG  components  may  be  hidden  in  the  insoluble 
pellets after extraction. These are not accessible to our ana- 
lyrical strategy because  stronger solubilization conditions 
such as SDS-contalning buffers inactivate the chondroitinase 
ABC enzyme used to reveal the core glycoprotein(s). In par- 
allel experiments, mAb 473HD reacted with a polydisperse 
smear of 1,000 kD comigrating with the material recognized 
by the polyclonal antibodies  in undigested CNS  homoge- 
hates. The epitope was, however, removed by chondroitinase 
ABC treatment, indicating that mAb 473HD recognizes the 
GAG complement of DSD-1-PG (Fig.  4,  and  see below). 
Analogous results were obtained when El8 rat hippocampi 
were used instead of postnatal mouse brains for the prepara- 
tion of CNS tissue extracts, subsequent digestion with chon- 
droitinase ABC and Western blotting with mAb 473HD or 
pDSD-1-PG, documenting that the molecule is expressed in 
this region of the nervous system during the period of neu- 
ritogenesis (not shown). 
To examine whether this epitope is only expressed on a 
subpopulation  of DSD-1-PG,  mAb  473HD  and  the poly- 
clonal pDSD-1-PG antibodies were compared in immuno- 
fluorescence double-labeling studies performed on mouse 
cerebellar cultures.  As already reported, rnAb 473HD re- 
acted with glial, but not with neuronal surfaces in cultures 
prepared from embryonic, peri-, and postnatal tissue main- 
tained in culture for various time periods. Thus, ~50% of 
473HD-positive cells  contained  vimentin,  in  contrast  to 
1-10%  which ovedapped with GFAP,  markers of immature 
and mature astrocytes in this culture system. Furthermore, 
50% of mAb 473HD-positive ceils expressed 04 and 10% 
expressed O1, markers of immature and mature oligodendro- 
cytes, respectively (Fig.  5 and not shown). In contrast, no 
overlap with LI, a marker of postmitoric neurons, was ob- 
served (Fig. 6). Less than 1% of mAb 473HD-posirive cells 
expressed fibronectin, indicating that DSD-1-PG is absent 
from surfaces of fibroblast-like cells which may represent 
meningeal  cells  (not  shown).  Consistent with this  result, 
mAb 473HD did not stain the surface of El4 mouse fibro- 
blasts  and no mAb 473HD-posirive material could be en- 
riched from the supernatant of subcultured human embry- 
onic  fibroblasts  by  immunoaffinity chromatography on  a 
mAb 473HD affinity column. Finally, in embryonal cerebel- 
lar cultures some mAb 473HD-positive cells did not express 
any of the aforementioned markers (Fig. 5 and not shown). 
These  observations  suggest  that  DSD-1-PG  is  surface- 
expressed by the astrocyte and oligodendrocyte  lineages dur- 
ing earlier differentiation stages. The polyclonal DSD-1-PG 
antibodies recognized the  same cells as the mAb 473HD 
(Fig. 6). In some cases, mAb 473HD showed a more pro- 
nounced reactivity with the culture substrate than the poly- 
clonal antibodies, presumably because the latter display a 
lower affinity towards the intact as compared to the GAG- 
free molecule (Fig.  3).  To ascertain that lower expression 
levels of DSD-I-PG on seemingly unstained ceils are not 
overseen because of this reduced affinity, the cultures were 
digested with chondroitinase ABC prior to the immunofluo- 
rescence studies. This treatment removed the mAb 473HD- 
binding site from the cell surface, as expected, but did not 
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Control 
Extraction buffer  kD 
Western blot with 
mAb 473HD  pDSD-1-PG 
Control  Ch-ase ABC 
Chase ABC  kD  kD 
A,  10 mM Tris-HCl, 4  M guanidinium-HC1, 
5 mM EDTA, pH 7.4 
B,  140 mM NaCl, 4  mM KCI,  15 mM NaHCO3, 
10 mM glucose, 0.2 mM NaH2PO4-H20,  and 
0.2 mM KH:PO4,  pH 7.4 
C,  100 mM diethylamine,  100 mM NaCI,  and 
2  mM EDTA, pH 11.5 
D,  100 mM diethylamine, 60 mM 
N-octylglucopyranosid, and 2  mM EDTA, 
pH  11.5 
E, 20 mM Tris-HCl, 5 mM EDTA, and 60 mM 
N-octylglucopyranosid, pH 8 
E  l0 mM Tris-HCl, 2  M  Urea, 2 mM EDTA, 
and 2  mM EGTA, pH 8.5 
G, 50 mM Tris-HCl, 50 mM Na-acetate, and 
60 mM N-octylglucoside, pH 8 
600-1~00  none  600-1~00  350-400 
600-1~00  none  600-1~00  350-400 
600-1~00  none  600-1~00  350-400 
600-1~00  none  600-1~00  350-400 
600-1~00  none  600-1~00  350-400 
600-1~00  none  600-1~00  350-400 
600-1~00  none  600-1900  350-400 
Postnatal mouse brains were homogenized  in buffers A-G and extracts incubated with chondroitinase  ABC or under identical conditions without addition of enzyme 
(control) for 2 h at 370C. After SDS-PAGE  probes were subjected to Western blotting and filters developed with mAb 473HD or pDSD-I-PG and ~ZSbderivatized 
secondary reagents. As expected, the DSD-1 epitop¢ was sensitive to chondroitinase ABC while pDSD-I-PG reacted with a core glycoprotein  of 350-400 kD. Note 
that all extraction protocols yielded identical results. 
Figure 5. Expression of DSD-1-PG on glial cell surfaces. Cerebcllar cells from El7 (A-C) and P5 (D-I) mice were maintained for 3 (A-F) 
or 5 d  in vitro, respectively. Cultures were stained with 473HD followed by anti-rat FITC (B, E, and H), fixed and count~rstained with 
04 and anti-mouse TRITC (C) or additionally permeabilized and labeled with rabbit polyclonal antibodies to vimentin (F) or GFAP (I) 
and anti-rabbit TRITC. Note that part of the DSD-1-PG expressing cells carry 04, a marker for immature oligodendrocytes and that overlap 
of the DSD-l-epitope is more pronounced with vimentin than with GFAE marl~rs of immature and mature astrocytes, respectively. Bar, 
30 ~m. Figure 6. Absence of DSDA-PG from cerebeUar neuron surfaces. Postnatal cerebellar cells were cultivated for 3 d and surface stained 
with mAb 473HD (B and E) or mAb 324 to the adhesion molecule L1 (I) and anti-rat FITC, and subsequently  counterstained with pDSD-1- 
PG (KAF13[4]) (C and H) or polyclonal Ll-antibodies (F) and anti-rabbit Texas red. Note that rnAb 473HD and pDSD-I-PG show overlap- 
ping staining patterns and do not react with neuronal surfaces. Bar, 20/~m. 
modify the marker profile of cells immunostained with the 
polyclonal antibodies (not shown). The combined observa- 
tions indicate that mAb 473HD and pDSD-1-PG  react with 
the same or closely related molecular species. This conclu- 
sion  was  supported  by  sequential  immunoprecipitations 
carded out on the supernatants of biosynthetically labeled 
postnatal mouse cerebellar cultures. Both mAb 473HD and 
pDSD-1-PG  antibodies precipitated material comigrating as 
polydisperse smear of 1,000 kD in SDS-PAGE (Fig. 7, inset). 
In contrast, the rat IgM mAb clone H1 which stains the sur- 
face of  GFAP-positive astrocytes in culture did not yield a de- 
tectable immunoprecipitate, underlining the specificity of 
the procedure (not shown). Eight cycles of  immunoprecipita- 
tion with mAb 473HD removed virtually all material reac- 
tive with pDSD-1-PG  while, in a parallel experiment, eight 
cycles of immunoprecipitation with the polyclonal antibod- 
ies removed nearly to completion the antigen bound by mAb 
473HD.  Based  on  these  measurements,  we  estimate that 
mAb 473HD and pDSD-1-PG  antigens are more than 95 % 
identical or,  in other words,  that the mAb 473HD  GAG- 
epitope is expressed on the majority, if not all, DSD-1-PG 
molecules and not restricted to a subpopulation of DSD-1- 
PG. The total immunoprecipitated radioactivity for both the 
mono- and the polyclonal  antibody corresponded to less than 
3 % of the incorporated activity, which was independently 
determined by TCA or acetone precipitation. Thus, DSD-1- 
PG represents a minor fraction of the labeled components in 
the culture supernatant, excluding unspecific depletion of the 
molecule by repeated immunoprecipitation cycles. 
mAb 473HD Reacts with the 
Chondroitin Sulfate/Dermatan Sulfate Hybrid 
GAG Structure DSD-1 
To characterize the site recognized by mAb 473HD,  anti- 
body binding was determined by ELISA after digestion of 
DSD-1-PG with GAG-lyases. In these experiments, the reac- 
tivity of mAb 473HD proved resistant to treatment of DSD- 
1-PG with heparinase, heparitinase, and keratanase, which 
did not significantly modify the migration behavior of DSD- 
1-PG in SDS-PAGE (Figs. 2 and 8 A). Chondroitinase ACII, 
which degrades CS A and CS C, but not CS B, slightly re- 
duced, whereas chondroitinase ABC, which cleaves CS A, 
CS B, and CS C abolished the binding of mAb 473HD to 
the molecule (Fig. 8 A). This hints towards a participation 
of DS (CS B) in the formation of the epitope. Notably, the 
selective removal of GAGs did not detach the residual PG 
core from the ELISA plate, as demonstrated by the specific 
binding of pDSD-1-PG  (Fig. 3) or of mAb 336 against the 
L2/HNK-1 carbohydrate epitope after treatment of DSD-1- 
PG with chondroitinase ABC (Fig. 8 A). The latter observa- 
tion indicates that the PG core is a glycoprotein and shares 
the N-linked L2/HNK-I carbohydrate with several cell adhe- 
sion molecules and neural proteoglycans. Partial reduction 
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tial immunoprecipitation.  P3 mouse cerebellar  cultures were bi- 
osyntheticaUy labeled with 3sSO4 and supernatants  were used for 
several cycles of  immunoprecipitation with pDSD-1-PG followed by 
mAb 473HD (A) or for the reverse order (B). Note that precipitates 
obtained  with  mAb 473HD and pDSD-1-PG comigrate in SDS- 
PAGE on 4--10% gradient  slab gels (fluorography, inset) and that 
each antibody virtually  removed the precipitable  activity  for the 
other. Bars detail the fractions of the total precipitated activity col- 
lected in the steps of one sequence of immunoprecipitations. 
of mAb 473HD  binding  to  DSD-1-PG by  chondroitinase 
ACII may reflect that CS A or CS C sequence motives con- 
tribute, in addition to CS B, to the structure of the epitope. 
To evaluate this contention, the effects of chondroitinase ACI 
and of chondroitinase ACII, which degrade CS A and CS C 
by random and  by stepwise  attack,  respectively, on mAb 
473HD binding to DSD-1-PG were compared (Hiyama and 
Okada,  1976).  Both chondroitinase ACI and ACII removed 
the reactivity for mAb CS-56, which is specific for CS A and 
CS  C  (Avnur  and  Geiger,  1984),  confirming  efficient 
removal of these GAGs from DSD-1-PG (Fig.  8 B).  As ex- 
pected, the binding of pDSD-1-PG was not affected by treat- 
ment with GAG-lyases (Fig. 8 B). These enzymes, however, 
exhibited  differential  effects  towards  the  mAb  473HD- 
binding site in that chondroitinase ACI eliminated whereas 
chondroitinase ACII only slightly altered reactivity of mAb 
473HD  with  DSD-1-PG  (Fig.  8  B).  Neither  enzyme de- 
grades intact DS polymers (Fransson and Havsmark, 1970; 
Figure 8.  Sensitivity of the DSD-1 epitope to glycosaminoglycan 
lyases. (.4) Purified DSD-1-PG (2 #g/ml uronic acid equivalents, 
100 #I per spot) was adsorbed to nitrocellulose filters using a dot 
blot apparatus and digested with glycosaminoglycan lyases as indi- 
cated  under  each column.  ELISAs  were performed with  mAb 
473HD (10 #g/ml) and mAb 336 (specific for the L2/HNK1 carbo- 
hydrate epitope [Kruse et al., 1984], 10 #g/ml) as indicated in the 
figure.  Note that the DSD-1 epitope is specifically  removed by 
chondroitinase  ABC,  in contrast  to the  L2/HNK-1 epitope.  (B) 
Purified DSD-1-PG (0.5 #g/ml uronic acid equivalents, 100 #1 per 
well) was adsorbed  to  PVP plates.  ELISA was performed with 
mono- and polyclonal antibodies on untreated DSDA-PG (control 
conditions)  or  DSD-I-PG digested  (test  conditions)  with  chon- 
droitinases ACI (0.1 unit/ml) and ACII (0.1 unirdrnl) as detailed in 
the figure. Note that the mAb 473HD epitope  is specifically re- 
moved by chondroitinase ACI but not by chondroitinase ACII, in 
contrast to the CS-56 epitope which is degraded by both enzymes. 
In all experiments (A and B) OD405 values obtained for each anti- 
body on untreated DSD-1-PG (control) were set 100%. OD4o5 was 
determined for antibody binding after various enzyme treatments 
(test conditions) and expressed as %-fraction of control using the 
equation  % of control  =  OD405~t/OD40~ou~l. At least four mea- 
surements were performed per treatment,  bars  indicate  standard 
deviations. The results of representative  experiments are shown. 
Schwarz et al.,  1990;  Gu et al.,  1993).  Furthermore,  it is 
known that chondroitinase ACII is competitively inhibited by 
iduronic acid containing dimers, the building blocks of DS, 
and in particular does not cleave iduronidic linkages (Heine- 
gard  and  Sommarin,  1987;  Seikagaku  Company,  1991). 
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473HD  binding  by  soluble 
GAGs.  Purified  DSD-1-PG 
(0.5 #g/ml uronic acid equiva- 
lents, 100 gl per well) was ad- 
sorbed  to  PVP-plates.  mAb 
473HD (10 gg/ml) was prein- 
cubated with GAGs (50 gg/ml) 
as indicated under the hatched 
columns  and  subsequently 
used  for ELISA  in the pres- 
ence  of  the  carbohydrate 
chains. Note that CS C com- 
petitively inhibits the binding 
of mAb 473HD to the DSDA 
epitope,  in  contrast  to  the 
other  components.  The % of 
control  OD4o5 was calculated 
as  described  in  legend  to 
Fig. 7. 
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Thus, this result is consistent with the view that rnAb 473HD 
binds  to  a  CS/DS-hybrid  GAG  structure  on  DSD-1-PG. 
Therefore,  the  structure identified by mAb 473HD on the 
glial CNS proteoglycan was named DSD-l-epitope (for der- 
matan-sulfate-dependent no.  1). The conclusion that DSD-1 
constitutes a GAG hybrid is supported by the inability of der- 
matanase,  a  GAG-lyase which attacks GAGs composed of 
DS polymers, to eliminate the DSD-l-epitope (not shown). 
Consistent with this result,  preincubation of rnAb 473HD 
with DS polymers did not prevent the binding of  the antibody 
to DSD-1-PG (Fig. 9). Similarly, CS A, heparin, HS, KS or 
dextran sulfate did  not interfere with the binding  of rnAb 
473HD  to DSD-1-PG when added as  soluble competitors 
to the ELISA (Fig. 9).  In contrast, CS C  successfully sup- 
pressed  the  interaction  of mAb 473HD  with  DSD-I-PG. 
These combined results  suggest that the  DSD-l-epitope is 
presumably created by insertion of iduronic acid into a CS 
C  framework, probably by epimerization. ThL assertion is 
supported by experiments performed with GAGs adsorbed to 
nitrocellulose carriers, Indeed, mAb 473HD readily bound 
to immobilized CS C but did not react with CS A, CS B, KS, 
and dextran sulfate as determined by ELISA (not shown). 
mAb 473HD also reacted with CS C spotted onto nitrocellu- 
lose after digestion with chondroitinase ACII, but not with 
CS C  degraded by chondroitinase ABC, indicating that the 
DSD-l-epitope might be contained in CS C preparations (not 
shown). It is noteworthy that the residual DSD-l-epitope ac- 
counts only for a  minor portion of the GAG-moieties, be- 
cause both chondroitinase ACI and ACH digestion of DSD-1- 
PG result in a  major component of comparable molecular 
weight  (Fig.  2),  although  chondroitinase  ACII leaves the 
GAG-epitope DSD-1  intact. 
DSD-1-PG Promotes Neurite Outgrowth 
To gain insight into the function of DSD-1-PG, its influence 
on the morphological differentiation of neurons was inves- 
tigated. When embryonic day 18 (El8) hippocampal neurons 
were  grown  on  PORN-covered  plastic  conditioned  with 
purified DSD-1-PG, the fraction of process-bearing cells in- 
creased with augmenting coating concentrations of the PG. 
A maximal effect on neurite outgrowth was obtained at 2.5 
#g/ml uronic  acid  equivalents  and,  therefore,  a  saturating 
Figure 10.  Concentration-dependent  promotion of neurite  out- 
growth by DSD-1-PG. (A) El8 hippocampal neurons were seeded 
at low density  in tissue culture plastic chamber slides on PORN 
substrates coated with DSD-1-PG at concentrations as indicated on 
the abscissa, fixed and stained with toluidine blue after 24 h of cul- 
ture.  The proportion  of process bearing  cells was determined  as 
fraction of at least 100 cells per well selected at random and given 
in %. At least 400 neurons from at least two independent experi- 
ments were analyzed for each concentration,  the curve is based on 
the quantitation of >5,100 neurons. (B) El4 mesencephalic or El8 
hippocampal neurons were grown for 24 h in tissue culture plastic 
chamber slides on PORN or PORN coated with 5 #g/ml uronic acid 
equivalents DSD-1-PG, as indicated in the figure. After the culture 
period the neurons were fixed, stained with toluidine blue, and the 
fraction of process-bearing cells was determined.  At least 100 neu- 
rons (n) were counted per well and at least one well was evaluated 
per  independent  experiment  (N).  Columns  show fractions  of 
process-bearing  ceils for El4 mesencephalic  (control: n >  1,300, 
N =  5, DSD-I-PG: n > 1,500, N =  9) and El8 hippocampal (con- 
trol: n > 4,400, N =  20, DSD-1-PG: n > 2,400, N =  12) neurons 
and bars indicate the standard deviations. For both mesencephalic 
and hippocampal neurons the increase of the fraction of process- 
bearing ceils on PORN/DSD-I-PG substrates was highly significant 
(p <  0.001 according to the unpaired  Student's t tes0. 
concentration of 5 #g/ml uronic acid equivalents of DSD-1- 
PG  was used for further experiments (Fig.  I0 A).  Under 
these  conditions,  the  fraction of process  bearing  El4  rat 
mesencephalic and  El8  rat hippocampal neurons  was en- 
hanced by 160 and  100%,  respectively, after 24 h as com- 
pared to the PORN control without PG (Fig. 10 B). In addi- 
tion, the process bearing neurons exhibited a more elaborate 
morphology and longer processes on DSD-I-PG-containlng 
substrates than on the PORN control (Fig.  11). This impres- 
sion was confirmed by the systematic morphometric analysis 
of process bearing neurons which demonstrated that DSD-I- 
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hippocampal neurons on DSD-1- 
PG--containing  polyornithine 
substrates. El8 hippocampal neu- 
rons were grown in tissue culture 
plastic chamber slides on PORN 
(A)  and  PORN  coated  with  5 
/~g/ml DSD-I-PG (B). Cells were 
fixed after 24 h and stained with 
toluidine blue. Note the increased 
process  lengths on  the  PORN/ 
DSD-1-PG substratum (B).  Bar, 
50 ~m. 
PG increased neurite lengths (by 65%) (Fig.  12,  Table II). 
The stimulatory effect of DSD-1-PG on neurite elongation 
was strongly reduced by mAb 473HD, suggesting that the an- 
tibody reacts  with  a  functionally important  structure.  To 
confirm that iduronic acid-containing GAGs are involved in 
neurite outgrowth, the DSD-1-PG/PORN culture substrate 
was digested with GAG-lyases prior to the addition of neu- 
rons.  Under these conditions,  chondroitinase ABC  which 
cleaves, but not chondroitinase ACII which spares the DSD-1 
epitope, abolished promotion of neurite elongation by DSD- 
1-PG (Fig.  12,  Table II).  The efficiency of chondroitinase 
ACII  treatment  was  monitored  with  mAb  CS-56,  which 
confirmed removal of  the majority of GAGs from the culture 
substrate  (not  shown).  The  neurite  outgrowth  promoting 
effect of DSD-1-PG was, like the DSD-1 epitope, resistant to 
heat treatment of the molecule (not shown). To exclude that 
the GAG-lyase or antibody treatments removed the PG, cul- 
ture substrates were examined by ELISA with pDSD-1-PG 
antibodies after coating, after enzyme digestion prior to cell 
plating and at the end of the 24-h culture period. In all of 
these  cases  DSD-1-PG  and/or  its  core glycoprotein were 
clearly demonstrable and no mitigation of the ELISA signal 
could be visualized (not shown). Thus, with respect to en- 
zyme digestions and antibody incubations the culture sub- 
strates behaved like the carriers of the ELISAs (Figs.  3, 8, 
and 9). We conclude from these results that the CS/DS hy- 
brid GAG chain DSD-1  is crucial for the neurite outgrowth 
and elongation promoting properties of DSD-1-PG. In view 
of inhibitory properties of CSPGs observed in various sys- 
tems, DSD-1-PG was also examined in a repulsion assay on 
patterned  substrates  (Faissner  and  Kruse,  1990).  When 
coated at 5 tzg/ml uronic acid, the concentration used for the 
neurite outgrowth studies, no repulsive properties of DSD-1- 
PG were observed (not shown). 
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Figure 12. Length distribution of hippocampal neurites on DSD-1- 
PG-containing substrates.  Neurites  of El8 hippocampal  neurons 
cultured as described in the legend to Fig.  10 were morphometri- 
tally analyzed and neurite lengths plotted in a frequency distribu- 
tion histogram.  The graph gives the relative fraction of hippocam- 
pal neurons (ordinate) with neurites longer than a given length in 
#m (abscissa) on different substrates as indicated in the figure. Total 
neurite lengths of 100 process-bearing  neurons chosen at random 
from two wells (one experiment) were plotted for each culture con- 
dition.  According to the Mann-Whitney U-test neurite length dis- 
tributions on PORN, on PORN/DSD-1-PG treated with chondroi- 
tinase ABC or with mAb 473HD did not significantly differ from 
each other while neurite length distributions on PORN/DSD-1-PG 
or  PORN/DSD-1-PG  treated  with  chondroitinase  ACII  were 
statistically equivalent and deafly distinct from the first group 09 
< 0.001). Ch-ase ACII: chondroitinase  ACII, Ch-ase ABC: chon- 
droitinase  ABC. 
Discussion 
We describe in our report that mAb 473HD identifies DSD- 
1-PG on the surface of young astrocytes and oligodendro- 
cytes and can be used to isolate the CSPG from postnatal 
mouse  brain.  As  salient  feature,  DSD-1-PG  contains  the 
hitherto undescribed CS/DS hybrid GAG structure DSD-1 
which is specifically recognized by rnAb 473HD.  Purified 
DSD-1-PG  promotes  neurite  outgrowth  from  embryonic 
CNS neurons, an effect which involves the DSD-l-epitope. 
mAb 473HD Reacts with the CS/DS Hybrid Epitope 
DSD-1 on DSD-1-PG 
The  specificity  of rnAb  473HD  has  been  established  by 
Western blotting, by immunoaflinity isolation of DSD-1-PG 
from detergent-free  physiological  saline  mouse  brain  ex- 
tracts, by immunoprecipitation and by ELISA. Differential 
digestion of DSD-1-PG with GAG-lyases revealed that the 
epitope  recognized by mAb 473HD  is  sensitive to  chon- 
droitinases  ABC  and  ACI and resistant  to chondroitinase 
ACII. The latter enzyme is competitively inhibited by DS 
with a Ki of 6.1  ×  10  -s M  (as moles of repeating disaccha- 
ride units) (Hiyama and Okada,  1977).  Selective resistance 
to  chondroitinase  ACII and  sensitivity  to  chondroitinase 
ABC  can be used as operational criterium  for the identi- 
fication of DS-motives (Heinegard  and  Sommarin,  1987; 
Schwarz et al.,  1990; Seikagakn Company, 1991; Gu et al., 
1993). Therefore, we propose DSD-1 as a name for the epi- 
tope (for dermatan-sulfate-dependent no.  1).  Alternatively, 
other biochemical modifications such as galactosaminogly- 
can-containing GAG sequences would have to be assumed 
(Hascall et al.,  1972; Rauch et al.,  1986).  At present, it is 
not  known  whether  these  chemical  modifications  are  se- 
lectively  distinguished  by  chondroitinases  ACI  and  ACU 
(Hiyama and Okada, 1976; Heinegard and Sommarin, 1987) 
and KS motives could not be identified in DSD-1-PG. For 
these reasons, the hypothesis that the mAb 473HD-binding 
site involves DS motives seems the most plausible at present, 
although a more precise assessment will require thorough 
and  detailed  structural  investigations.  Interestingly, chon- 
droitinase ACII degrades GAGs in a  stepwise manner and 
might be blocked by DS segments in the vicinity of the core 
glycoprotein. These might still be accessible to chondroitin- 
ase ACI which proceeds by multiple random attack (Hiyama 
and  Okada,  1976).  Digestion  of  DSD-1-PG  with  chon- 
droitinases ABC or ACII results in major glycoprotein cores 
with similar molecular mass. This could indicate that the re- 
Table II. Quantitative Analysis of  Neurite Lengths on DSD-1-PG/PORN Substrates 
Neurite length  %  stimulation  %  inhibition 
of 50 cells  SD  SE  as compared  as compared  Experiments  Ceils 
Substrate  ~m  ~rn  ~m  to control  to DSD-1-PG  N  n 
PBS (control)  4774  1095  234  -  -  12  1100 
DSD-1-PG  7749  1729  397  64.7  +  18.0"  -  12  950 
DSD-1-PG + 
mAb 473HD  5658  1403  389  15.3 +  10.15  76.6 +  13.6"  7  650 
DSD-1-PG + 
Ch-ase ACII  7132  1071  378  61.5 +  13.5"  -5.3  +  22.5 (ns)  5  400 
DSD-1-PG + 
Ch-ase ABC  4872  1051  350  8.8  +  14.2 (NS)  85.4 +  24.6*  5  450 
Hippoeampal neurons were cultured under different conditions and morphometrically analyzed. Since neurite lengths were not normally distributed, values for 
50 process-beating neurons per individual well were collected at random and summed. At lease 400 neurons from at least five independent experiments were sam- 
pied. The average values and corresponding standard deviations of the single sums and the % increase or decrease of summed neurite lengths within independent 
experiments were calculated. The significance  of the difference between the mean values of s~ neurite lengths was estimated with the Mann-Whitney U-Test 
and  is indicated next to  the  %  stimulation of neurite lengths of the  %  inhibition of DSD-1-PG  effect,  Percentages were calculated as  %  stimulation S  = 
(I.~  -  l-,,~m,a)/~  and %  inhibition of DSD-1-PG effect I  =  (S~  -  SaSD-I-r~)/SDsD-I,VC. Ch-ase AC and ABC, chondroitinase AC or ABC, respectively; SE, 
standard error of the mean; N, number of independent experiments; n,  number of single cells; and L, total neurit¢ length of 50 neurons. 
* 0.0001  <  p  <  0.001. 
$ 0.01  <  p  <  0.05. 
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PG.  The  failure of dermatanase which requires a  motive 
composed of several  iduronlc acid constituents to remove, 
the inability of purified DS to compete for the mAb 473HD- 
binding site, and the fact that chondroitinases ACI and ACII 
do not cleave pure DS imply that DSD-1 is a hybrid structure 
(Fransson and Havsmark,  1970;  Michelacci and Dietrich, 
1975). To our knowledge, 473HD is the first mAb with this 
reactivity profile. This might explain why the DSD-l-epitope 
shows a restricted expression while CSPGs have been found 
on the surface of most cell types, including neurons (Za- 
remba et al.,  1989;  Lander, 1993,  for review). Systematic 
comparison of pDSD-1-PG  and mAb 473HD by double im- 
munofluorescence and sequential immunoprecipitation ex- 
periments performed on postnatal mouse cerebellar cultures 
demonstrated that the DSD-l-epitope is present on the major 
fraction and not only a subset of DSD-1-PG. DSD-1-PG mi- 
grates as a  single peak in ion exchange and size exclusion 
chromatography and contains a prominent glycoprotein of 
molecular mass 350-400 kD upon removal of its GAG con- 
stituents. Polyclonal antibodies generated against DSD-1-PG 
react with polydisperse material of 1,000-kD molecular mass 
both in Western blotting and in immunoprecipitation experi- 
ments and detect a prominent band of 350-400 kD in CNS 
extracts digested with chondroitinase ABC, consistent with 
the properties of purified DSD-1-PG.  No substantial addi- 
tional bands were detected by various extraction techniques, 
yet the existence of further components not accessible to our 
procedures cannot be excluded. Therefore, the precise deter- 
mination of DSD-1-PG glycoprotein core(s) and their poten- 
tial variants will require molecular cloning of the PG. 
DSD-I-PG Promotes Neurite Outgrowth 
To obtain insight into the potential function of DSD-1-PG, 
we have cultured El4 mesencephalic and El8 hippocampal 
neurons at low density on DSD-1-PG/PORN substrates. Un- 
der these conditions, DSD-1-PG promoted neurite outgrowth 
in that the fraction of process-bearing neurons and total neu- 
rite lengths were augmented by 100 and 65 %, respectively, 
in comparison to neurons growing on PORN controls. The 
neurite outgrowth promoting effect was  resistant to  heat 
treatment and nearly reduced to control levels by addition of 
rnAb 473HD  to the culture medium,  suggesting that the 
DSD-1 hybrid GAG structure is involved. This conclusion 
was confirmed by differential digestion of the culture sub- 
strate where chondroitinase ACII spared while chondroitin- 
ase ABC removed both the DSD-1 epitope and the neurite 
outgrowth promoting property of DSDq-PG.  It is unlikely 
that the effect is caused by neutralization of the polycationic 
poly-DL-ornithine culture substrate because elimination of 
most  of  the  negatively  charged  GAG  chains  by  chon- 
droitinase ACII does not mitigate neurite outgrowth promo- 
tion, In view of its expression, DSD-1-PG might thus con- 
tribute to the influence of immature astrocyte surfaces on the 
shaping of neuronal assemblies and fiber extensions (Rakic, 
1988).  Support of neurite growth by PGs has already been 
documented. For example, HS, DS, and CS GAGs potentiate 
neurite outgrowth by PC12 cells upon exposure to aFGF, 
bFGF, and NGF (Damon et al.,  1988),  HS,  DS,  and CS 
GAGs induce neurite outgrowth and in part stimulate the de- 
velopment of  polarity in El4 mesencephaiic neurons (Lafont 
et al., 1992) and the combined core proteins of three soluble 
postnatal rat brain CSPGs promote neurite outgrowth from 
El6 rat embryonic neurons (Iijima et al., 1991). The neurite 
growth promoting properties described in these publications 
and our study contrast, however, with inhibitory influences 
of CS GAGs or CSPGs on neurite growth reported by other 
groups. For example, embryonic chick DRG neurites do not 
grow out in a three-dimensional HEMA-gel culture system 
containing heparin, CS, and hyaluronic acid (Carbonetto et 
al.,  1983),  avoid DS, CS, and hyaluronic acid adsorbed to 
collagen type I (Verna et al., 1989) and spots ofa CS/KSPG 
isolated from bovine cartilage on a plain laminin or N-CAM 
substrate (Snow et al.,  1990b).  Similarly, the developmen- 
tally regulated KSPG  claustrin  from  embryonic chicken 
brain inhibits the growth of El2 optic lobe neurites from 
laminin-containing into laminin/claustrin-coated areas,  an 
effect probably involving the KS chains (Snow et al., 1990b; 
Cole and McCabe,  1991). In embryonic chick epidermis, a 
CSPG prevents embryonic chick DRG neurite ingrowth into 
epidermal explants in an in vitro coculture system and anti- 
bodies to CS neutralize this effect (Verna,  1985; Fichard et 
al., 1991). Another report has attributed inhibition ofneurite 
outgrowth by CSPGs to the core glycoproteins rather than 
to the GAG moieties (Oohira et al.,  1991). The repulsive 
effects of GAGs have mainly been observed in choice situa- 
tions where neurites were confronted with favorable sub- 
strates, e.g., collagens, laminin, and N-CAM on the one side 
and areas of the culture dish containing GAGs and/or PGs 
in addition on the other side. There are precedents that mole- 
cules displaying repulsive or inhibitory activities in choice 
situations may permit, or even enhance neurite growth or 
cell  migration  as  homogeneous  substrates,  for  example 
tenascin (Crossin et al.,  1990;  Faissner and Kruse,  1990; 
Wehrle and Chiquet,  1990;  Lochter et al.,  1991; Taylor et 
al., 1993; reviewed in Faissner, 1993; Faissner and Schach- 
ner,  1994)  or laminln (Calof and Lander,  1991). Whether 
this is also true of DSD-1-PG will have to be studied. Our 
immunofluorescence double-labeling studies with different 
glial cell markers have established that DSD-1-PG is detect- 
able on the surfaces of immature astrocytes and oligodendro- 
cytes and down-regulated with maturation in both lineages. 
Consistent with this conclusion, preliminary studies have 
localized DSD-1-PG to gliai boundaries, e.g., in the develop- 
ing somatosensory cortex of the mouse (Steindler et al., 
1990). 
Relationship of DSD-1-PG to Other PGs 
Judged  by  biochemical  criteria,  DSD-1-PG  could be  in- 
cluded in the soluble CSPG fractions of rat brain or in the 
PG core glycoproteins expressing the L2/HNK-1 carbohy- 
drate epitope (Kiang et al., 1981; Klinger et al., 1985; Oo- 
hira et al., 1988; Gowda et al., 1989; Herndon and Lander, 
1990; Rauch et al., 1991). It is unlikely that the neurite out- 
growth promoting CSPGs recently described in rat CNS are 
related to DSD-1-PG  because these express mostly CS A 
(80%) and CS C  (20%), but not DS and do not contain a 
comparable  core  protein  (Oohira  et  al.,  1988;  Iijima et 
al.,  1991). Neurocan, which also expresses the L2/HNK-1 
epitope, has a  core glycoprotein of 150 kD,  distinct from 
DSD-1-PG (Rauch et al., 1991, 1992; Grumet et ai., 1993). 
DSD-1-PG  differs  also  from  the  embryonic  chick  brain 
cytotactin-binding  PG  or  from  CAT-301  because  these 
CSPGs are expressed by neurons, unlike DSD-1-PG  which 
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Hoffman et al.,  1988;  Zaremba et al.,  1989).  DSD-1-PG 
seems also distinct from the T1 antigen, a CSPG with a ma- 
jor core glycoprotein of 300 kD, because T1 requires dena- 
turing conditions for purification and is barely contained in 
salt extracts  from rodent brain,  in contrast to DSD-1-PG 
(Iwata and Carlson,  1993). In terms of molecular weight of 
the core glycoprotein and of cellular specificity, DSD-1-PG 
is  reminiscent  of the  CSPG  NG2  (Stallcup  and  Beasley, 
1987;  Stallcup et al.,  1990;  Nishiyama  et al.,  1991).  Yet 
polyclonal  anti-NG2  antibodies  do  not  cross-react  with 
DSD-1-PG both before and after treatment with GAG-lyases 
(Streit, A., W. Stallcup, A. Faissner, M. Schachner, unpub- 
lished observations). Finally, DSD-1-PG is also distinguish- 
able from the CSPG astrochondrin  (Streit et al., 1990,  1993) 
which is expressed by mature, GFAP-positive astrocytes and 
not by oligodendrocytes, while DSD-1-PG shows a nearly re- 
verse  distribution  pattern.  In  support  of this  notion,  as- 
trochondrin does not promote neurite outgrowth (Streit et 
al., 1993) and is hence also functionally distinct from DSD- 
1-PG. It is interesting that mAb 473HD detects a CS C-epi- 
tope that is sensitive to both chondroitinases ABC and ACI 
in human peripheral nerve proteoglycan fractions which are 
immunologically  cross-reactive  with versican and decorin 
antibodies (Braunewell, K.-H., R. Martini, R. LeBaron, H. 
Kresse, A. Faissner,  B.  Schmitz and M.  Schachner, manu- 
script in preparation). However, versican so far has not been 
detected during embryonic CNS development and has been 
reported to be produced by fibroblasts, while DSD-1-PG is 
present in El3 mouse CNS and barely detectable in primary 
fibroblast cultures (Faissner,  A., A.  Clement, unpublished 
observations;  Zimmermann and Ruoslahti,  1989;  Bignami 
et al.,  1993).  In contrast, versican has recently been docu- 
mented  in  peri-  and  postnatal  rat  brain  (Bignami  et  ai., 
1993). The available data relating to GAG composition, mo- 
lecular weight of the core glycoprotein(s), distribution, and 
function are compatible with the possibility that DSD-1-PG 
might be related to versican and represent a novel member 
of the growing aggrecan family (reviewed by Lander,  1993). 
The more precise evaluation  of possible similarities to and 
differences from other CSPGs will require information about 
the primary  structure  of DSD-1-PG. 
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